<DOC>
	<DOCNO>NCT02504554</DOCNO>
	<brief_summary>This open-label clinical trial investigate combination therapy treat gastrointestinal problem child autism spectrum disorder . The combination therapy include beneficial bacteria .</brief_summary>
	<brief_title>Beneficial Bacteria Treatment</brief_title>
	<detailed_description>This open-label clinical trial evaluate safety , tolerability , feasibility combination therapy treat gastrointestinal problem child autism spectrum disorder . It involve combination therapy include beneficial bacteria .</detailed_description>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>1 . Children age 717 year 2 . Diagnosis autism per Autism Diagnostic InterviewRevised ( ADIR ) 3 . Moderate Severe GI problem ( GSRS , single score 4 ( severe ) item , score 3 ( moderate ) two item , score 2 ( mild ) 4 item 4 . No change medication , supplement , diet , therapy , education last 3 month , intention change clinical trial 5 . General good physical health aside gastrointestinal problem 6 . Cognitive Ability Provide Informed Assent 1 . Antibiotics last 6 month 2 . Probiotics last 3 month 3 . Singlegene disorder ( Fragile X , etc . ) 4 . Major brain malformation 5 . Tube feed 6 . Severe gastrointestinal problem require immediate treatment ( lifethreatening ) 7 . Ulcerative Colitis , Crohn 's Disease , diagnose Celiac Disease , Eosinophilic Gastroenteritis , similar condition 8 . Severely underweight/malnourished 9 . Recent schedule surgery 10 . Current participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>child</keyword>
</DOC>